Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2019 4
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations.
Madariaga A, Lheureux S, Oza AM. Madariaga A, et al. Cancers (Basel). 2019 Mar 23;11(3):416. doi: 10.3390/cancers11030416. Cancers (Basel). 2019. PMID: 30909618 Free PMC article. Review.
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer.
McMullen M, Karakasis K, Madariaga A, Oza AM. McMullen M, et al. Among authors: madariaga a. Cancers (Basel). 2020 Jun 17;12(6):1607. doi: 10.3390/cancers12061607. Cancers (Basel). 2020. PMID: 32560564 Free PMC article. Review.
Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events.
Madariaga A, Bowering V, Ahrari S, Oza AM, Lheureux S. Madariaga A, et al. Int J Gynecol Cancer. 2020 Jul;30(7):903-915. doi: 10.1136/ijgc-2020-001288. Epub 2020 Apr 9. Int J Gynecol Cancer. 2020. PMID: 32276934 Free PMC article. Review.
Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment?
Madariaga A, Goodwin PJ, Oza AM. Madariaga A, et al. Clin Cancer Res. 2020 Feb 1;26(3):523-525. doi: 10.1158/1078-0432.CCR-19-3645. Epub 2019 Nov 26. Clin Cancer Res. 2020. PMID: 31772118
Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers.
Madariaga A, Rustin GJS, Buckanovich RJ, Trent JC, Oza AM. Madariaga A, et al. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e152-e166. doi: 10.1200/EDBK_238755. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099646 Free article. Review.
[Ipilimumab-induced colitis: A new challenge for gastroenterologists].
Mesonero F, López-Sanromán A, Madariaga A, Soria A. Mesonero F, et al. Among authors: madariaga a. Gastroenterol Hepatol. 2016 Mar;39(3):233-8. doi: 10.1016/j.gastrohep.2015.06.005. Epub 2015 Aug 20. Gastroenterol Hepatol. 2016. PMID: 26298799 Review. Spanish.
Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer Patients.
Mezquita L, Benito A, Ruano-Raviña A, Zamora J, Olmedo ME, Reguera P, Madariaga A, Villamayor M, Cortez SP, Gorospe L, Santón A, Mayoralas S, Hernanz R, Cabañero A, Auclin E, Carrato A, Garrido P. Mezquita L, et al. Among authors: madariaga a. Clin Lung Cancer. 2019 Jul;20(4):305-312.e3. doi: 10.1016/j.cllc.2019.04.009. Epub 2019 May 3. Clin Lung Cancer. 2019. PMID: 31151782
A comprehensive review of poorly differentiated neuroendocrine carcinomas (pdNECs): a niche to find novel opportunities.
Reguera P, Madariaga A, Grande E. Reguera P, et al. Among authors: madariaga a. Curr Pharm Des. 2014;20(42):6644-51. doi: 10.2174/1381612820666140826154033. Curr Pharm Des. 2014. PMID: 25341936 Review.
COVID-19 Testing in Patients with Cancer: Does One Size Fit All?
Madariaga A, McMullen M, Sheikh S, Kumar R, Liu FF, Zimmermann C, Husain S, Zadeh G, Oza AM. Madariaga A, et al. Clin Cancer Res. 2020 Sep 15;26(18):4737-4742. doi: 10.1158/1078-0432.CCR-20-2224. Epub 2020 Jul 2. Clin Cancer Res. 2020. PMID: 32616498 Review.
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression.
Lheureux S, Oaknin A, Garg S, Bruce JP, Madariaga A, Dhani NC, Bowering V, White J, Accardi S, Tan Q, Braunstein M, Karakasis K, Cirlan I, Pedersen S, Li T, Fariñas-Madrid L, Lee YC, Liu ZA, Pugh TJ, Oza AM. Lheureux S, et al. Among authors: madariaga a. Clin Cancer Res. 2020 Aug 15;26(16):4206-4215. doi: 10.1158/1078-0432.CCR-19-4121. Epub 2020 May 22. Clin Cancer Res. 2020. PMID: 32444417
15 results
Jump to page